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Atomic force microscopy (AFM)Epidermal growth factor receptor (EGFR) plays an important role in signaling pathway of the development of
breast cancer cells. Since EGFR overexpresses in most breast cancer cells, it is regarded as a biomarker molecule
of breast cancer cells. Here we demonstrated a new AFM technique—topography and recognition (TREC)
imaging—to simultaneously obtain highly sensitive and speciﬁc molecular recognition images and high-
resolution topographic images of EGFR on single breast cancer cells.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Epidermal growth factor receptor (EGFR) is a member of receptor
tyrosine kinase (RTK) family of signaling proteins. It was the ﬁrst mam-
malian signaling protein to be fully characterized [1]. The activation of
EGFR is normally controlled by the interaction with their ligands such
as EGF and TGF-α, providing cells with substantial differentiation and
growth advantages [2]. However, it has been found that aberrant ex-
pression or activation of EGFR appears to be an important factor in
both the initiation and the progression of human cancer [3–5]. For ex-
ample, in human breast carcinoma (EGFR positive), expression of
EGFR was reported to support the existence of tumor cells with aggres-
sive potentials [6]. The expression level of EGFR in metastatic breast tu-
mors was often higher than primary tumors, indicating that EGFR was
involved in the process of metastasis [7,8]. Overexpression and abnor-
mal function of EGFR and its ligands have been found in many different
types of human cancers [5]; thismakes it a great prognostic indicator for
the development of malignancies. Furthermore, therapeutic strategies
have been developed, using small biomolecules (e.g. kinase inhibitors)
and large molecules (e.g. monoclonal antibodies) to block the binding
of EGFR and its ligands, consequently blocking receptor activation and
transduction of post-receptor signals [9,10].
Recent study has shown that EGFR functionality can be dependent
on its subcellular location andmis-located EGFRmay regulate tumor re-
sponse to therapy [11]. Therefore, localization of EGFR on cancer cells is
of great importance. However, it is very challenging to probe the spatialgineering, Utah State University,
97 2863; fax:+1 435 797 1248.and temporal distribution of speciﬁc cell receptors and their signaling-
related molecular actions in molecular cell biology [12,13]. In recent
years, sophisticated technologies have been developed to achieve the
identiﬁcation and localization of those biomolecules in cells. Among
them are (1) ﬂuorescence imaging with improved spatial resolution,
which can offer the approach to monitor the dynamic information
about the localization, distribution of biomolecules and their cell-
signaling actions [14,15]; (2) electron-dense probes and electron
microscopy, which provide nanometer resolution in characterizing
and mapping membrane receptors and signaling molecules [16]; (3) a
combination of quantitative mass spectrometry and cryo-electron to-
mography, providing insights into the distribution of speciﬁc protein
complexes in cytoplasm [17,18]. Although these advanced technologies
have signiﬁcantly improved capability of detecting and localizing cell
receptors, some limitations still remain: low spatial and temporal reso-
lution, the requirement of physiological and dynamic condition, and
low chemical speciﬁcity. Few techniques can overcome all these limita-
tions and provide critical measurements of cell membrane receptors.
Since its invention in 1980s, atomic force microscopy (AFM) has be-
come a powerful tool technique for analyzing the morphology of indi-
vidual molecules at nanometer scale and the forces acting on them
with piconewton sensitivity. As to the study of biological samples,
AFM presents signiﬁcant advantages than other microscopic methods
since it allows single-molecule level studies of the structure and interac-
tion of complicated biomolecules and cells with nanometer spatial
resolution [19], and it allows samples to be measured in liquid phase
(e.g., culture medium), enabling the study of dynamic interactions be-
tween biomolecules under physiological condition. Simultaneous To-
pography and RECognition (TREC) imaging, a new AFM technique
based on the high-resolution topographic imaging and single-molecule
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with high spatial and temporal resolution, providing exceptional infor-
mation that is complementary to that obtained byﬂuorescence andelec-
tron microscopy [22]. For example, TREC imaging has been successfully
used to visualize, at the ﬁrst time, the localization and distribution of
Na+-K+ ATPases in the inner leaﬂet of cell membranes at single-
molecule level [23]; by employing TREC, the local organization of Fcγ re-
ceptors on single macrophage cell has been determined at single-
molecule level [24]. In addition to cell receptor imaging, TREC imaging
technique has also been extensively used to monitor speciﬁc biomole-
cules while they are undergoing biological processes. Wang et al. [20,
25,26] applied TREC to study the action of human Swi-Snf nucleosome
remodeling complex and its interaction with mouse mammary tumor
virus promoter during the process of nucleosome remodeling. Besides,
they were also able to recognize the glycosylation process of biomole-
cules by using TREC imaging, and distinguish normal and aberrant anti-
bodies based on their glycosylation [27].
It has been known that BRMS1 is a member of metastasis suppres-
sors, which inhibit metastasis without blocking orthotopic tumor for-
mation in metastatic cascade [28,29]. Previous studies have shown
that the expression of BRMS1 in 435 cells regulates biomechanical prop-
erties including cell adhesion and cell elasticity [30], which probably are
induced by reorganization of cytoskeletal structures [31,32]. Also, it has
been reported that BRSM1 regulates the expression of growth factor re-
ceptors in 435 cells by differentiallymodulating their signaling pathway
[8]. Aberrant EGFR signaling results in many pathological diseases like
neural developmental disorders and cancer [33]. Furthermore, EGFR
signaling is mainly up-regulated in breast cancers through activation
of NF-κB activity, and BRMS1 has been shown to affect NF-κB activi-
ty [34,35]. To probe this link, we explored whether BRMS1 altered sig-
naling through EGFR. Our previous work [36] has conﬁrmed that
BRSM1 down-regulated the expression of EGFR in 435 breast carcinoma
cells. Further investigation is needed to address the question whether
BRMS1 affects the localized EGFR conformation, which has been
shown to be important in changing the binding kinetics of EGFR [37].
TREC imaging presented high speciﬁcity, reproducibility, and recogni-
tion efﬁciency at nanoscale. Therefore, TREC imaging method has been
applied in order to identify the local binding sites of EGFR on single
breast cancer cells.
Molecular recognition usingmonoclonal antibody (anti-EGFR) teth-
ered scanning tipwas converted to high-resolution topography and rec-
ognition images. The recognition efﬁciency was tested in a spatio-
temporal manner by introducing EGF as a competing ligand, when
conducting TREC imaging of EGFR using antibody-tethered AFM tips.
We measured the density and distribution of EGFR on breast cancer
cell lines—MDA-MB-435 (435) and 435 transfected with BRMS1 gene
(BReast cancer Metastasis Supressor 1 [38,39], 435BRMS1). These cell
lines provide excellent cellmodels for EGFR detection as BRMS1 expres-
sion has been shown to regulate EGFR expression in these cell lines [8].
In addition, the advantages of TREC imaging technique in monitoring
dynamic changes of cellular biomolecules have been discussed.
2. Materials and methods
2.1. Sample preparation and cell culture
For TREC imaging on mica, epidermal growth factor receptor (EGFR,
Life Technologies, Grand Island, NY) solution (0.21 mg/mL, in 0.1X PBS)
wasdropped onto newlypealedmica surface and left 10min for adsorp-
tion. Rinsed several times with DI water to wash away incompletely
adsorbed EGFR and then load mica onto sample plate for recognition
imaging. The adsorbed EGFR molecules were scanned and imaged in
0.1X PBS solution by TREC imaging technique.
435 and 435BRMS1 cells were generously provided by Dr. Danny
Welch from University of Kansas Cancer Center. 435BRMS1 cells were
transfected with a lentiviral vector construct expressing full-lengthBRMS1 cDNA under the control of a cytomegalovirus promoter [40].
435 and 435BRMS1 cells were cultured in a 1:1 mixture of Dulbecco's-
modiﬁed Eagle's medium (DMEM) and Ham's F-12 medium supple-
mented with 5% fetal bovine serum (Hyclone, Logan, UT). Cells were
cultured in 25-cm2 Corning tissue culture dishes at 37 °C with 5% CO2
in a humidiﬁed atmosphere. Cells were passaged at 80–90% conﬂuency
using 2 mM EDTA in Ca2+/Mg2-free PBS (PBS, 0.01 M, pH 7.4, Thermo
Scientiﬁc). Cell lines were conﬁrmed to be free of mycoplasma contam-
ination using PCR (TaKaRa-Clontech, Mountain View, CA). No antibi-
otics or antimycotics were used during routine culture. For TREC
imaging on cell surface, both living cells and ﬁxed (4% paraformalde-
hyde) were measured.
2.2. AFM tip functionalization
Magnetically coated silicon-nitride AFM tips (Type VI MAC Le-
vers, Agilent Technologies, Chandler, AZ) were functionalized with
anti-EGFR antibody using the method reported previously [20].
Brieﬂy, MAC levers were ﬁrst amino-functionalized with APTES
(aminopropyltriethoxysilane, Sigma-Aldrich, St. Louis, MO) under the
atmosphere of argon. Subsequently, after rinsing with methylene chlo-
ride (Sigma-Aldrich) for three times,MAC levers were attached to NHS-
PEG-SS-Pyr (MW 1634, PolyPure, Oslo, Norway) by incubating the tips
with the PEG linker for 2 h, with the presence of triethylamine. At the
same time, monoclonal antibody to EGFR (anti-EGFR, Life Technologies,
Grand Island, NY) was thiolated by reacting with N-succinimidyl 3-
(acetylthio) propionate (SATP, Sigma-Aldrich) and subsequently puri-
ﬁed in a PD-10 column (GE Healthcare). Finally, the thiolated antibody
was conjugated to the AFM tip via the PEG crosslinker by 1 h incubation
in deacetylation buffer (hydroxylamine hydrochloride and Triz Base,
Sigma Aldrich). Antibody functionalized MAC levers were then rinsed
with PBS buffer and stored in 4 °C before use. The morphologies of
antibody-modiﬁed MAC lever tips were imaged by scanning electron
microscopy (Hitachi S4000).
2.3. AFM recognition imaging
AFM recognition imaging was performed on a PicoPlus AFM system
with a PicoTREC attachment unit (Agilent Technologies). Topography
and recognition images were recorded simultaneously by using func-
tionalized MAC levers with nominal spring constant of 0.292 N/m. Dur-
ing TREC measurement, a half-amplitude feedback loop was used to
measure the unbiased topography. 8–10 nm free oscillation amplitude
and ~20 kHz driving frequency of the tips were chosen to obtain opti-
mized recognition images. All these parameters were set to make the
TREC measurements more easy, robust, and reliable [41]. Image pro-
cesses (including smooth, contrast adjustment) and the height and
widthmeasurements of testedproteinswere performed using PicoView
software (Agilent Technologies).
The single cell AFM images were taken under contact modewith the
instrument setting exactly the same as previously described [42,43].
2.4. TREC image processing
Weemployed an adaptive threshold-based segmentationmethod to
ﬁnd white spots in a topological image and dark spots in a recognition
image. We ﬁrst converted the original color image to a grayscale
image. For the recognition image, we also inverted its intensity so the
darkest spot turns to the brightest spot and vice versa. After this pro-
cessing, we aimed to separately ﬁnd white spots in the grayscale
image of the topological image and the inverted grayscale image of
the recognition image. To this end,we ﬁrst computed the average inten-
sity and the standard deviation of the grayscale image. The threshold
was then computed as the sum of the average intensity and the stan-
dard deviation. For the topological image, we simply marked any posi-
tion with the pixel intensity larger than the threshold as the white
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the pixel intensity larger than the threshold as the dark spot due to the
inversion process. Finally, we applied a logical “AND” operation to ﬁnd
the common areas shown up in both white spots of the topological
image and dark spots of its paired recognition image. These areas
were then overlaid on top of the original topological image to show
thewhite spots in topological image that have been simultaneously rec-
ognized in the recognition image as the dark spots.
We implemented the image segmentation method using Matlab
2012(b).
3. Results and discussion
3.1. Principle of TREC and its biological application
Scheme 1 brieﬂy shows the principle of TREC imaging method. The
basic principle of TREC imaging is based on small alterations in cantile-
ver oscillation amplitude that occur when tip-tethered antibodies bind
to their antigens. When the oscillating antibody-tethered AFM tip
scans through the sample, the tethered antibody binds to an antigen
on the surface and the upward oscillation of the cantilever is restricted
speciﬁc antibody–antigen binding force, leading to the decrease in the
oscillation amplitude. This reduction of amplitude is sensed by the mi-
croscope servo and converted into reduction of the recognition signal
(peak voltages). Therefore, a map of recognition signals, together with
simultaneously generated topographic image, localizes the antibody–
antigen binding events with pairs of bright and dark spots showing on
the image.
Applications of TREC technique in biomedical research is certainly an
increasingly demanding task. Up to now, TREC imaging method hasScheme 1. Schematic illustratiobeen applied to visualize quite a few different biomolecule systems,
such as biotin–avidin [44,45], ligand–receptor [46,47], and antibody–
antigen interactions [20,23]. In this study, we utilized TREC imaging to
visualize EGFRmolecules on complex cell membrane surface, providing
a newexample of the applications of thismethodology in biomedical re-
search. Due to the signiﬁcant role of EGFR in cancer research, our work
appears to inspire an alternative nanoscale instrument technique to pri-
mary cancer diagnostics. Furthermore, TREC approach has the potential
to study the dynamic activation process of EGFR,which is of great signif-
icance, because EGFR can be activated by its speciﬁc ligands (e.g. EGF,
TGF-α), leading to the growth and spread of tumor [48].
3.2. Functionalization and SEM characterization of AFM MAC lever
Functionalization of AFM MAC lever tips with anti-EGFR antibody
was the key point to achieve successful TREC measurements. As
shown in Fig. 1a, a procedure with four steps involved has been imple-
mented to conjugate anti-EGFR monoclonal antibody with AFM tip to
construct an EGFR-speciﬁc AFM nanosensor tip. It should be noted
that, in this method, a PEG chain was applied to link the tip and the an-
tibody due to its ﬂexibility that allows for reorientation of the targeting
molecule when the tip approaches the surface [49,50]. The free oscilla-
tion amplitude was set comparable to the extended length of the PEG
linker (~8 nm) so that antibody on the tip remained bounding to the an-
tigen on the surface during imaging and kept high lateral accuracy as
well [50]. The morphologies of bare MAC lever tip (Fig. 1b) and anti-
EGFR antibodies modiﬁed tip (Fig. 1c) were characterized by scanning
electron microscope (SEM). It is clearly seen that the morphology of
modiﬁed probe was different from bare probe with the presence of
“bumps” or “clusters” on the surface.n of the TREC experiment.
Fig. 1. (a) Conjugation of AFMMAC lever: (1)MAC lever amination; (2) linkMAC leverwith PEG linker (MW1634); (3) antibody activation by SATP; (4) SATP-antibody conjugate to AFM
tip. (b) SEM image for bare tip. (c) SEM image for anti-EGFR functionalized tip.
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To evaluate the feasibility and efﬁciency of this TREC imagingmeth-
od, we ﬁrst chose mica as the substrate, since it's ﬂat at atomic level,
making it suitable to imaging the antibody–antigen interaction. EGFR
molecules were adsorbed onto the mica surface through electrostatic
interaction. When anti-EGFR antibody-tethered AFM tip approached
the surface and scanned through the surface, antibody–antigen recogni-
tion events were recorded by simultaneously generated images of the
surface topography (Fig. 2a) and recognition (Fig. 2b) signals. “Bright
spots” in Fig. 2a represent single molecules or aggregates of EGFR, and
the corresponding “dark spots” in Fig. 2b represent the recognition
events of EGFR. The numbers and positions of “bright spots” in topogra-
phy imagematch those “dark spots” in recognition image, indicating the
antibody–antigen recognition occurred. These events were originated
from the tip-tethered antibody binds to antigens, restricting the tip to
oscillate upwards and leading to the reduction of the oscillation ampli-
tude. To test the speciﬁcity of the recognition process, an anti-EGFR an-
tibody solution (20 μg/mL) was injected via a liquid ﬂow cell to block
the interaction between tip-tethered anti-EGFR and EGFR on the sur-
face. After 10 min adsorption, “dark spots” on recognition image were
disappeared when conducting scan on the same location (Fig. 2c). The
inset image in Fig. 2c was the corresponding topography image after
block control experiment, which showed similar feature pattern but a
small shift in the feature locations. The location shiftwas due to interfer-
ence of the system caused by injection of free anti-EGFR solution. Cross-
section line proﬁling analysis along the recognition events (red and
green lines on Fig. 2a, b, and c) showed that before free anti-EGFR
blocking, there were signiﬁcant recognition signals (Fig. 2e) observed
by the twopairs ofmatchingpeaks in both topography (Fig. 2d) and rec-
ognition (Fig. 2e) images; however, as blocked by excess speciﬁc anti-
body, recognition signals of the antigens were dramatically decreased
(Fig. 2c, f). Furthermore, as a control experiment, bare tipwas employed
to scanEGFR onmica surface (Fig. S1a). Apparent “bright spots” features
on topography imagewere presented, while no featureswere shown on
recognition image. After a BSA solution (50 μg/mL) was injected and letadsorbed for 10 min, recognition events still appeared as antibody-
tethered tip scanning on the surface (Fig.S1b), showing that non-
speciﬁc protein–protein interaction wouldn't affect the recognition. All
these results indicate the recognition events were highly speciﬁc—only
EGFR molecules were recognized when sensing with anti-EGFR
antibody-tethered AFM tip.
Efﬁciency of the EGFR recognitionwas also tested onmica. As shown
in Fig. 3, bright spots in topography image and dark spots in recognition
image were labeled by a pair of green dots, representing a pair of recog-
nition events took place. In this typical image, almost all features (45 out
of 47) in topography imagewere recognized, indicating perfect recogni-
tion efﬁciency of this TREC imaging method to detect EGFR through
speciﬁc antibody–antigen interaction. In addition, to test the reproduc-
ibility of recognition, the sample was rescanned at the same position.
Only a few changes labeled with blue dots and circles had happened
in the rescan of the same area, showing generally high reproducibility
of the recognition.
3.4. EGF effects on TREC imaging of EGFR
EGF acts as a competing ligand that may affect the recognition of
EGFR by AFM tip-tethered anti-EGFR. To investigate how EGF affects
the antibody–antigen recognition between EGFR and its antibody, we
applied TREC imaging to measure EGFR on mica with and without EGF
presence. As shown in Fig. 4, when EGFR was presented alone on the
mica surface (Fig. 4a), the recognition events (green) occurred or over-
lapped at the most of the “bright spots” area, indicating the high recog-
nition efﬁciency between the tip-tethered antibody and the EGFR;
however, the TREC image scanned at 10min after EGF (20 μg/mL) intro-
duction (Fig. 4b) showed only reduced level of recognition, revealing
the incomplete blocking by EGF on the binding sites between EGFR
and its antibody. Analyses ofmultiple images show that the average rec-
ognition percentage dropped from 84.3 ± 3.4% (n = 3) to 57.4 ±
13.53% (n = 3) when EGF is presented as a competitor (Fig. 4c). Com-
paring the partial block by EGF with the complete block by anti-EGFR
antibody (Fig. 2c), it is suggested that, under this experimental
Fig. 2. Speciﬁcity of recognition. (a) Topographic image and (b) corresponding recognition image of EGFR (5 μg/mL) on mica. (c) Recognition image of EGFR after blocking by free anti-
EGFR antibody (20 μg/mL). Inset: topography image corresponding with (c). (d, e, f) Cross-section analysis along the red and green line in (a, b, c). Red and green circles show the ampli-
tude change (recognition peaks) in corresponding topography and recognition images where the recognition events occur. Scan area: 500 nm*500 nm.
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for than of EGFR to EGF. Measurements of the binding kinetics are im-
portant in understanding the activation mechanism of EGFR. PreviousFig. 3. Efﬁciency of recognition events. A pair of green dots in topography (a) and correspondin
cation, changes in recognition events are labeled in the same recognition image (b). Green dot su
second scan; blue dots represent recognition events appeared in the second scan but not in thstudies have shown that the binding kinetics between EGF and EGFR
signiﬁcantly vary under different EGFR conformation in cells [37,51,
52]. However, to our knowledge, there is no study comparing theg recognition (b) images represents a recognition event. After rescanning at the same lo-
rrounded by a blue circlemeans a recognition event appears in theﬁrst scan but not in the
e ﬁrst scan. Scan area: 2000 nm*2000 nm.
Fig. 4. Effect of EGF on the recognition of EGFR on mica. Recognition events of EGFRs (green) superimposed on corresponding topography images before (a) and 10 min after (b) the in-
troduction of EGF solution (20 μg/mL). (c) EGF effect on recognition percentage. Data acquired from three consecutive scans (N50 features in each scan) at different locations, and present-
ed as mean ± SD.
Fig. 5. Fixed single 435 and 435BRMS1 cells' morphologies and their EGFR expression mea-
sured by TREC. (a–d) are the topography images (a, b) and corresponding deﬂection im-
ages (c, d) of single (a, c) 435 and (b, d) 435BRMS1 cells. (e, f) are recognition events of
EGFRs (green) superimposed onto corresponding topography images of (e) 435 and
(f) 435BRMS1 cells.
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EGFR, whichmight be valuable in order to develop antibody-based can-
cer therapy through EGFR, and worth further investigation.
3.5. TREC imaging of EGFR on 435 and 435BRMS1 cells
After evaluation of imaging EGFR on mica, it is necessary to assess
the performance of this EGFR-modiﬁed AFM-tip nanosensor in imaging
EGFR on breast cancer cell surfaces. Morphologies of ﬁxed single meta-
static 435 and non-metastatic 435BRMS1 cells were visualized by contact
mode AFM, and their morphologies have been shown to be very differ-
ent (Fig. 5a–d). Typical topography and deﬂection images of 435 cells
are shown in Fig. 5a and c, respectively. The shape of 435 cells was ob-
served to be round-like, which is typical for metastatic cancer cells
[30,53]. Nevertheless, as shown in Fig. 5b and d, the 435BRMS1 cell has
an elongated morphology comparing with the 435 cell. Changes in cell
morphology caused by BRMS1 transfection have also been previously
reported [30]. While features like chemosensitivity were not signiﬁ-
cantly affected by BRMS1 [54], the BRMS1 did regulate the expression
of several cellular receptors, such as EGFR [8,36].
TREC imagingmethod was carried out to further probe the local dis-
tribution of EGFR molecules on the membrane surface of ﬁxed 435 and
435BRMS1 cells. Comparing with the TREC images on mica surface, the
images on cells were less distinct with the distribution of EGFR due to
the complexity of cell membrane surface. We then applied an image
segmentation method to ﬁnd out the corresponding “recognition
sites” by comparing topography and recognition images, and superim-
pose the recognitions sites (green) onto corresponding topography im-
ages taken from central area of theﬁxed 435 (Fig. 5e) and 435BRMS1 cells
(Fig. 5f). It is found that EGFR heterogeneously distributed on both 435
and 435BRMS1 cells and tended to form domains with a scale of tens of
nanometers. However, this observation was obtained on the ﬁxed
cells, which may not reﬂect the real EGFR distribution on living cells.
In addition, it is also required to conduct living cell measurements in
order to image the dynamic changes of the cell receptors.
Fig. 6a shows the recognition of EGFR in living 435 cells using TREC
imaging technique. Comparing with the ﬁxed 435 cell, the living 435
cell exhibits a more uniform EGFR local distribution, and small domains
of about 10 nm in scale weremainly observed. The presence of recogni-
tion events was also conﬁrmed by the corresponding peaks through
cross-session proﬁling curves, though with reduced amplitudes, oc-
curred in the line proﬁles along the images (Fig. 6b). The smallest recog-
nition events showing the binding sites of EGFR molecules were
nanometer scale (~5 nm), which is comparative to the size of single
molecule of EGFR [55], indicating that TREC is able to achieve analysis
of biomolecules at single-molecule level. However, since TREC imaging
is based on amplitudemeasurements, it is unable to quantitatively con-
ﬁrm the single-molecule level recognition, which is usually measuredby AFM-based single-molecule force spectroscopy [21,56]. Even though,
TREC provides nanoscale imaging resolution, making it applicable to
monitor the conformational changes of cell surface receptors during bi-
ological processes. Furthermore, the whole imaging process was done
within several minutes, which means TREC imaging has potential to in
situmonitor many biological processes such as the activation of EGFR
molecules by their speciﬁc ligands (e.g. EGF, TGF-α).
Fig. 6. (a) Recognition image of EGFRs (green) superimposed on corresponding topography images of 435 cell. (b) Cross-section proﬁle along the red line in (a). Corresponding peakswere
occurred at the positions of recognition sites, indicating the recognition events.
1994 L. Xiao et al. / Biochimica et Biophysica Acta 1848 (2015) 1988–19954. Conclusions
This work reported an AFM-based topography and recognition
(TREC) imaging technique for targeting and imaging cancer biomarker
EGFR in single human breast cancer cells. It achieved high speciﬁcity,
reproducibility, and efﬁciency in EGFR recognition by using an
antibody-tethered AFM tip. By imaging EGFR molecules before and
after EGF introduction. It demonstrated the potential to monitor the
ligand-receptor interaction at molecular level. Furthermore, the TREC
imaging technique successfully probed the heterogeneous distribution
of EGFR, with nanoscale spatial resolution, on the plasma membrane
of single breast cancer cells, under the inﬂuence of Breast cancerMetas-
tasis Suppressor 1 (BRMS1). This TREC imaging technique can be used
as a powerful imaging tool to study different cell surface receptors at
molecular level, which is important and still challenging, in physiologi-
cal and pathological studies.
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